| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Operating loss | -7 | 0 | -30 | -20 |
| Other expense (income) | 1 | -2 | - | -216 |
| Interest expense, net | -9 | -8 | -9 | -6 |
| Loss before income taxes | -15 | -10 | -39 | -242 |
| Income tax provision (benefit) | -1 | -1 | -8 | 1 |
| Net loss | -14 | -9 | -31 | -243 |
| Basic weighted-average common shares outstanding (in shares) | 168,578,000 | 168,525,000 | 168,023,000 | 134,095,000 |
| Diluted weighted-average common shares outstanding (in shares) | 168,578,000 | 168,525,000 | 168,023,000 | 134,095,000 |
| Earnings per share, basic (in dollars per share) | -0.08 | -0.05 | -0.18 | -1.81 |
| Earnings per share, diluted (in dollars per share) | -0.08 | -0.05 | -0.18 | -1.81 |
RXO, Inc. (RXO)
RXO, Inc. (RXO)